Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
41
ADN Quote, Financials, Valuation and Earnings
Last price:
$5.34
Seasonality move
:
-28.79%
Day range:
$4.35 - $4.93
52-week range:
$1.71 - $8.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.35x
P/B ratio:
1.66x
Volume:
15.2K
Avg. volume:
14.8K
1-year change:
-10.18%
Market cap:
$12.9M
Revenue:
$4.9M
EPS (TTM):
-$27.40
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Advent Technologies Holdings has 176.64% upside to fair value with a price target of -- per share.
ADN vs. S&P 500
-
Over the past 5 trading days, Advent Technologies Holdings has overperformed the S&P 500 by 28.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Advent Technologies Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Advent Technologies Holdings has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Advent Technologies Holdings reported revenues of $128K.
Earnings Growth
-
Advent Technologies Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Advent Technologies Holdings reported earnings per share of -$7.03.
Enterprise value:
12.7M
EV / Invested capital:
--
Price / LTM sales:
1.35x
EV / EBIT:
--
EV / Revenue:
1.41x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
1.87x
Price / Operating cash flow:
1.80x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$9.4M
Return On Assets:
-225.31%
Net Income Margin (TTM):
-719.24%
Return On Equity:
-1041.26%
Return On Invested Capital:
-1023.62%
Operating Margin:
-6192.97%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $8.8M | $4.2M | $9M | $112K | $128K | |
| Gross Profit | -$87K | -$2.5M | -$9.4M | -$695K | -$208K | |
| Operating Income | -$52M | -$44.3M | -$66.9M | -$9.8M | -$7.9M | |
| EBITDA | -$49.2M | -$41.5M | -$64.2M | -$9.3M | -$7.9M | |
| Diluted EPS | -$21.00 | -$52.68 | -$27.40 | -$5.89 | -$7.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $108.4M | $61.3M | $23.5M | $1.4M | |
| Total Assets | -- | $174M | $127.5M | $55.4M | $7.3M | |
| Current Liabilities | -- | $15.4M | $14M | $12.8M | $25.1M | |
| Total Liabilities | -- | $37.8M | $20.1M | $22.8M | $25.4M | |
| Total Equity | -- | $136.1M | $107.4M | $32.6M | -$18.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$43.3M | -$36.2M | $7.2M | -$17.3M | $7.9M | |
| Cash From Investing | -$5.5M | -$16.6M | $109K | -$645K | -- | |
| Cash From Financing | -- | $5.5M | $3.9M | $2.1M | -$540K | |
| Free Cash Flow | -$48.5M | -$50.9M | $6.8M | -$18M | $7.9M | |
ADN
Sector
Market Cap
$12.9M
$611.3M
Price % of 52-Week High
55.52%
74.03%
Dividend Yield
0%
0%
Shareholder Yield
-67.66%
2.49%
1-Year Price Total Return
-10.18%
-5.84%
Beta (5-Year)
0.442
0.892
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.50
200-day SMA
Buy
Level
$4.03
Bollinger Bands (100)
Sell
Level
3.52 - 6.34
Chaikin Money Flow
Sell
Level
-539.9K
20-day SMA
Buy
Level
$4.79
Relative Strength Index (RSI14)
Buy
Level
52.06
ADX Line
Sell
Level
18.98
Williams %R
Sell
Level
-14.8397
50-day SMA
Sell
Level
$5.23
MACD (12, 26)
Sell
Level
-0.20
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
301.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.1555)
Sell
CA Score
(Annual)
Level (-4.029)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (11.4554)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
Stock Forecast FAQ
In the current month, ADN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADN average analyst price target in the past 3 months is --.
-
Where Will Advent Technologies Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Advent Technologies Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Advent Technologies Holdings?
Analysts are divided on their view about Advent Technologies Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Advent Technologies Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Advent Technologies Holdings's Price Target?
The price target for Advent Technologies Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ADN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Advent Technologies Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ADN?
You can purchase shares of Advent Technologies Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Advent Technologies Holdings shares.
-
What Is The Advent Technologies Holdings Share Price Today?
Advent Technologies Holdings was last trading at $5.34 per share. This represents the most recent stock quote for Advent Technologies Holdings. Yesterday, Advent Technologies Holdings closed at $4.88 per share.
-
How To Buy Advent Technologies Holdings Stock Online?
In order to purchase Advent Technologies Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
